3988 - Natera - Tampa - Breast Cancer V6e (1)
Watch Video
Watch Video
Watch Video
Clinical Applications for Signatera in Breast Cancer Surveillance
Watch Video
Real World Case Study: Personalized ctDNA Testing for High Risk Breast Cancer Surveillance
Watch Video
Clinical utility of personalized ctDNA testing in breast cancer treatment
Watch Video
Clinical applications of ctDNA testing for MRD assessment in breast cancer
Watch Video
Watch Video
Webinar presents new ctDNA data from ASCOGU in muscle invasive bladder cancer and metastatic renal cell carcinoma
Watch Video
Clinical applications to support management of patients with high risk breast cancer
Watch Video
This webinar will explore the expanding role of circulating tumor DNA (ctDNA) for assessing molecular residual disease (MRD) and monitoring treatment response in patients with colorectal cancer.
Watch Video
Applications of personalized ctDNA testing to optimize treatment decisions in patients with GI cancers, presented by Dr. Adham Jurdi, MD
Watch Video
Watch Video
Watch Video
Watch Video
Watch Video
Watch Video
Watch Video
Watch Video
Many ongoing studies aim to improve treatment and outcomes for early-stage colorectal cancer, including guiding adjuvant chemotherapy decisions and bringing targeted therapies and immunotherapies into
Watch Video
Watch Video
Loading More...